Patients with inflammatory conditions and multiple sclerosis can overcome barriers to taking their medications with the help of financial assistance programs.
As the industry’s first actionable adherence solution, ScreenRx® combines early detection with tailored interventions to improve member adherence and deliver healthcare savings to clients.
Our study, presented at the NORD Rare Summit, shows the positive impact interventions can have on medication adherence for people with rare disease.
Accredo's holistic rare disease patient care yields a 27% increase in medication adherence.
To date, ScreenRx has closed 37% of medication adherence gaps and has recorded $188.6 million in total healthcare savings for our clients.
This first-to-market value-based program improves patient engagement and increases medication adherence while reducing costs for some of the costliest therapies.
Express Scripts’ new Cardiovascular Care ValueSM program expands on our SafeGuardRx® Cholesterol Care ValueSM program to holistically tackle the clinical and financial...